Stock Track | PROCEPT BioRobotics Soars 5.07% as Q4 Earnings Showcase Robust Growth and New Product Success

Stock Track
02-26

PROCEPT BioRobotics (PRCT) stock surged 5.07% in intraday trading on Wednesday, following the company's impressive Q4 2024 earnings report that highlighted strong revenue growth and the successful launch of its new AI-enabled Hydro robotic system.

The company reported a 57% year-over-year increase in total revenue for Q4 2024, reaching $68.2 million, driven by increased sales of its Aquabeam and Hydro robotic systems, as well as a surge in procedures performed. Full-year 2024 revenue grew by an impressive 65% compared to the previous year.

A key driver of PROCEPT's growth was the introduction of the Hydro robotic system, featuring advanced AI and ultrasound integration, which has been well-received in the market. The company achieved a 60% growth in its US installed base, with 505 systems by the end of 2024, and the Hydro system accounted for 95% of new system sales in Q4.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10